Company: PIII
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001628280-25-026021
Chunk: 15

Company: P3 Health Partners Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 15
---
4 Promissory Note in-kind.Amendment to Term Loan Agreement and Consent In connection with the transactions described above, P3 LLC entered into (1) the Seventh Amendment to Term Loan Agreement (the “Term Loan Amendment”), dated as of February 13, 2025, by and among P3 LLC, as borrower, the subsidiary guarantors party thereto, the lenders from time to time party thereto and CRG, as administrative agent and collateral agent and (2) the Consent (the “Consent”), dated as of February 13, 2025, by and between P3 LLC, as borrower, and VBC Growth SPV, LLC (“VGS”), as holder. The Term Loan Amendment and Consent collectively permit the issuance of the VGS 4 Promissory Note and the entry into the VGS 4 Subordination Agreement by P3 LLC.

Note 9: Net Loss per ShareThe following table provides the computation of basic and diluted net loss per share:Three Months Ended March 31,20252024(in thousands, except per share data)Numerator–basic:Net loss attributable to Class A common stockholders–basic$(20,480)$(18,700)Numerator–diluted:Net loss attributable to Class A common stockholders–basic$(20,480)$(18,700)Effective of dilutive securities:Shares of Class V common stock— — Net loss attributable to Class A common stockholders–diluted$(20,480)$(18,700)Denominator–basic:Weighted average Class A common shares outstanding–basic3,260 2,378 Net loss per share attributable to Class A common stockholders–basic$(6.28)$(7.86)Denominator–diluted:Weighted average Class A common shares outstanding–basic3,260 2,378 Weighted average effect of dilutive securities:Shares of Class V common stock— — Weighted average shares outstanding–diluted3,260 2,378 Net loss per share attributable to Class A common stockholders–diluted$(6.28)$(7.86)All periods presented in the table above have been retroactively adjusted to reflect the 1-for-50 reverse stock split effected on April 11, 2025. See Note 3 “Significant Accounting Policies” for further information.Shares of Class V common stock do not share in the earnings or losses of P3 and